David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Consumer Discretionary | 9.92% |
| 3 | Healthcare | 7.34% |
| 4 | Financials | 7.06% |
| 5 | Communication Services | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
Enterprise Financial Services Corp
EFSC
$2.29B
| $579K | ﹤0.01% |
+12,794
| New | +$573K |
|
3852
Luxfer Holdings
LXFR
$459M
| $579K | ﹤0.01% |
29,483
-7,421
| -20% | -$153K |
|
3853
CALL
Credicorp
BAP
$30.4B
| $577K | ﹤0.01% |
5,200
| – | – |
|
|
ICVX
3854
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $577K | ﹤0.01% |
+19,507
| New | +$661K |
|
3855
ANI Pharmaceuticals
ANIP
$1.74B
| $575K | ﹤0.01% |
17,515
-7,399
| -30% | -$230K |
|
3856
Deutsche Bank
DB
$73.4B
| $571K | ﹤0.01% |
44,926
| – | – |
|
3857
PUT
D.R. Horton
DHI
$42.2B
| $571K | ﹤0.01% |
6,800
-11,500
| -63% | -$1.06M |
|
3858
MasterCraft Boat Holdings
MCFT
$599M
| $570K | ﹤0.01% |
+22,712
| New | +$582K |
|
|
LFC
3859
DELISTED
China Life Insurance Company Ltd.
LFC
| $570K | ﹤0.01% |
347,000
-2,673,000
| -89% | -$22.9M |
|
3860
ALX Oncology
ALXO
$277M
| $569K | ﹤0.01% |
7,710
-38,109
| -83% | -$2.54M |
|
3861
CarParts.com
PRTS
$49M
| $569K | ﹤0.01% |
3,645
-132
| -3% | -$22.9K |
|
|
EB
3862
CALL
DELISTED
Eventbrite
EB
| $567K | ﹤0.01% |
30,000
-120,000
| -80% | -$2.11M |
|
3863
Exponent
EXPO
$3.33B
| $567K | ﹤0.01% |
5,010
-26,487
| -84% | -$2.86M |
|
3864
Pool Corp
POOL
$6.77B
| $563K | ﹤0.01% |
1,297
-34,443
| -96% | -$16.3M |
|
3865
HBT Financial
HBT
$1.3B
| $562K | ﹤0.01% |
36,174
+77
| +0.2% | +$1.25K |
|
3866
GSK
GSK
$104B
| $561K | ﹤0.01% |
11,751
+3,971
| +51% | +$199K |
|
3867
CALL
Franco-Nevada
FNV
$52.4B
| $559K | ﹤0.01% |
4,300
-900
| -17% | -$132K |
|
|
OSG
3868
Octave Specialty Group
OSG
$203M
| $558K | ﹤0.01% |
38,990
-30,008
| -43% | -$428K |
|
3869
AYTU BioPharma
AYTU
$25.2M
| $557K | ﹤0.01% |
9,668
+4,872
| +102% | +$366K |
|
3870
Heritage Financial
HFWA
$1.18B
| $554K | ﹤0.01% |
21,726
+9,480
| +77% | +$230K |
|
3871
PUT
Gaotu Techedu
GOTU
$410M
| $553K | ﹤0.01% |
180,000
+40,000
| +29% | +$202K |
|
3872
Northwest Bancshares
NWBI
$2.24B
| $551K | ﹤0.01% |
41,489
-85,659
| -67% | -$1.13M |
|
3873
Stoneridge
SRI
$205M
| $550K | ﹤0.01% |
26,996
+4,617
| +21% | +$114K |
|
|
SPPI
3874
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $550K | ﹤0.01% |
252,625
-320,773
| -56% | -$876K |
|
3875
CALL
NXP Semiconductors
NXPI
$56.7B
| $548K | ﹤0.01% |
+2,800
| New | +$581K |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.